Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
92.96 USD | +2.23% | -0.36% | +16.62% |
May. 28 | Morgan Stanley Raises Price Target on Colgate-Palmolive to $103 From $101 | MT |
May. 16 | Colgate Palmolive Insider Sold Shares Worth $2,094,940, According to a Recent SEC Filing | MT |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's high margin levels account for strong profits.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company benefits from high valuations in earnings multiples.
- With an enterprise value anticipated at 4.05 times the sales for the current fiscal year, the company turns out to be overvalued.
- The company appears highly valued given the size of its balance sheet.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+16.62% | 74.6B | A+ | ||
+12.28% | 384B | C- | ||
+12.61% | 136B | B- | ||
-12.57% | 66.27B | A- | ||
-15.65% | 43.53B | B+ | ||
-10.36% | 36.36B | - | ||
+6.37% | 34.72B | B- | ||
+7.80% | 17.91B | A- | ||
+12.30% | 15.64B | B | ||
-2.17% | 11.73B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- CL Stock
- Ratings Colgate-Palmolive Company